Sustainable Bioprocessing Materials Market Sees Steady Growth as Biopharma Adopts Bio-based Polymers

A new report published in October 2025 by Precedence Research highlights that the global market for sustainable bioprocessing materials is set to experience substantial growth from 2024 through 2034. These materials, which include bio-based, biodegradable, recyclable, and hybrid polymers used in biopharmaceutical manufacturing, are becoming critical to the drive for a net-zero and circular economy production model in life sciences.

Key Market Insights

In 2024, North America held approximately 46.5% of global market revenue, making it the dominant region. Europe, however, is projected to grow at the fastest compound annual growth rate (CAGR) during the forecast period, supported by regulatory momentum and a strong biopharma base.

By material type, bio-based polymers captured the largest share at 43.6% in 2024, while the fastest-growing segment is expected to be compostable or biodegradable plastics. In terms of application, single-use bioprocessing equipment, such as bags, tubing, filters, and connectors, dominated with a 49.2% share. On the process-stage front, upstream processing held 44.9% of the revenue in 2024, while the fill-and-finish stage is expected to grow fastest.

End-users in the biopharmaceutical companies segment accounted for 61.3% of the market in 2024, with contract development and manufacturing organisations (CDMOs and CMOs) expected to expand at the highest rate over the next decade.

Why the Growth?

Several factors are driving this expansion. First, the global biopharmaceutical sector continues to grow, putting pressure on manufacturers to improve process efficiency, flexibility, and sustainability. The shift toward continuous processing, higher-titer cell lines, intensified manufacturing, and single-use systems has accelerated the demand for innovative materials that meet both performance and environmental criteria.

Second, regulatory and consumer pressures are increasing. Companies are under greater scrutiny to reduce carbon footprints, minimise waste, particularly plastic waste, and align operations with circular economy principles. Sustainable bioprocessing materials aim to reduce environmental impact while maintaining sterility, safety, and regulatory compliance.

Third, innovation in materials science is advancing rapidly. Bio-based feedstocks such as polylactic acid (PLA), polyhydroxyalkanoates (PHA), and bio-polyethylene (bio-PE) are gaining traction, alongside hybrid sustainable materials designed to balance performance and biodegradability.

Implications for Industry and Sustainability

For manufacturers of biologics, cell and gene therapies, vaccines, and other advanced therapies, the adoption of sustainable bioprocessing materials offers a dual benefit: it supports internal ESG targets while improving operational agility. Single-use systems made from bio-based or biodegradable materials can reduce reliance on fossil-based plastics, lessen cleaning and validation burdens, and enable faster change-overs between production batches.

Supply-chain and materials engineers, however, face trade-offs. While sustainable materials bring environmental benefits, they may present challenges in scalability, cost, recyclability, and regulatory validation. The report highlights scalability issues, higher initial costs, and the difficulty of recycling single-use plastics under strict GMP regulations as major obstacles.

For sustainability teams, the trend signals a deeper transformation. Beyond simply adopting greener materials, the sector is moving toward systemic circularity, including waste minimisation, process intensification, and energy and water efficiency across production.

Policy-makers and regulators will also play a critical role. The strong growth forecast underscores the need for enabling frameworks that incentivise sustainable manufacturing. In Europe, for instance, the combination of the European Green Deal, industrial decarbonisation policies, and investment in green innovation is expected to accelerate adoption.

Regional Outlook and Strategic Considerations

North America’s leadership is supported by a mature biopharma industry, strong healthcare investment, and regulatory support from agencies such as the US Food and Drug Administration. However, to maintain competitiveness, the region must strengthen its supply chains for bio-based feedstocks and develop recycling or reuse pathways for single-use systems.

Europe’s rapid growth reflects its ambitious sustainability targets, growing biomanufacturing capacity, and regulatory incentives for greener production methods. This creates opportunities for suppliers of sustainable materials and equipment to partner with biopharma companies seeking to decarbonise operations.

Asia-Pacific and emerging markets also represent strong potential. Expanding biopharmaceutical capacity in countries such as China, India, and Japan, along with government support for biotechnology innovation, is expected to fuel the adoption of sustainable materials across the region.

Looking Ahead

The sustainability transition in biomanufacturing is at a pivotal stage. As processes evolve toward continuous production, higher efficiencies, and reduced waste, material choices are becoming central to long-term environmental performance. The projected growth of the sustainable bioprocessing materials market reflects an industry-wide shift: materials are no longer a secondary consideration but a key enabler of green manufacturing.

For stakeholders across the life-sciences ecosystem, from materials suppliers and equipment manufacturers to contract producers and pharmaceutical firms, the next decade will demand strategic investments in R&D, validation, and collaboration. Aligning with sustainability frameworks and regulatory trends will be crucial to capitalising on this emerging market.

In the broader context of the low-carbon and circular economy transition, sustainable bioprocessing materials represent a small but important piece of the puzzle. Their adoption supports cleaner production, reduced emissions, and more responsible use of resources within one of the world’s most innovation-intensive industries.

Conclusion

The report concludes that the global sustainable bioprocessing materials market is poised for significant expansion through 2034. With leading segments such as bio-based polymers, compostable plastics, single-use equipment, and upstream bioprocessing driving growth, the biomanufacturing industry’s shift toward greener, more efficient processes is well underway. For companies and policy-makers alike, the direction is clear: sustainable materials will be central to the future of biomanufacturing.

Source: www.globenewswire.com